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Background: A metanalysis of 17 trials examining atrial function after radiofrequency catheter ablation of atrial fibrillation (RFCAF) concluded that 
successful ablation significantly decreases left atrium (LA) size and volumes and does not seem to adversely affect LA systolic function. We have 
cared for a few patients with symptomatic left atrial diastolic dysfunction with associated pulmonary hypertension that developed following catheter 
ablation for atrial fibrillation. Similar findings were described in patients following cardiac surgery and referred to as the “stiff left atrial syndrome”.
Objective: Therefore, we prospectively sought to quantify the prevalence of patients developing PH associated with diastolic hemodynamic 
abnormalities of the LA following RFCAF and to identify the possible predictors.
Methods:  Data on 1380 consecutive patients were prospectively collected. Before ablation and at follow up, all patients had an Echocardiogram 
to assess for the presence of pulmonary hypertension. Patients with no echocardiographic evidence of PH but complaining of unexplained dyspnea 
were evaluated with right heart catheterization. All patients were evaluated for pulmonary vein stenosis and excluded if this condition was identified.
Results:  The mean age was 62±11 (75% male) and non-paroxysmal AF was the predominant arrhythmia (71%). PH was detected in 19 (1.4%) 
patients after ablation. The prevalence of PH was significantly higher among non-paroxysmal AF patients (79%, vs. 25% in paroxysmal AF patients, 
p<0.001). Pre-procedure LA size < 4.5 cm (OR=6.13, p=0.033), mean LA pressure (OR 1.14, p =0.025), Severe LA scarring (OR=4.4, p=0.046), 
diabetes mellitus (OR=9.5, p=0.004), and obstructive sleep apnea (OR=6.2, p=0.009) were independently associated with the development of PH 
post ablation.
Conclusions:  Following RFCAF symptomatic left atrial diastolic dysfunction or “Stiff Left Atrial Syndrome” is rare but is a potential complication. 
Atrial scarring, LA < 4.5 cm, diabetes mellitus, obstructive sleep apnea and high LA pressure are clinical variables that predict the development of 
this syndrome.This information is relevant to the care of post ablation patients.
